Skip to main content

Peer Review reports

From: Novel therapies for resistant focal segmental glomerulosclerosis (FONT) phase II clinical trial: study design

Original Submission
19 Jan 2011 Submitted Original manuscript
24 Jan 2011 Author responded Author comments - Howard Trachtman
Resubmission - Version 2
24 Jan 2011 Submitted Manuscript version 2
Publishing
10 Feb 2011 Editorially accepted
10 Feb 2011 Article published 10.1186/1471-2369-12-8

You can find further information about peer review here.

Back to article page